[Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically]

Hautarzt. 2000 Aug;51(8):612-4. doi: 10.1007/s001050051180.
[Article in German]

Abstract

A 53 year old female patient developed a keratoacanthoma, present on the left side of her nose for two months. After repeated unsuccessful trials with cryotherapy, she was treated with intralesional injection of methotrexate performed twice with a weekly internal. This led to complete resolution within 5 weeks. Although controlled studies on the effect of methotrexate in keratoacanthoma are not available, the rapid regression and the good cosmetic result suggest that this therapy may play a beneficial role in treating these lesions especially in problem locations.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Dermatologic Agents / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intralesional
  • Keratoacanthoma / drug therapy*
  • Methotrexate / administration & dosage*
  • Middle Aged
  • Time Factors

Substances

  • Dermatologic Agents
  • Methotrexate